Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC.

The Journal of investigative dermatology - 1 Mar 2018

Hiller Julia, Hagl Beate, Effner Renate, Puel Anne, Schaller Martin, Mascher Birgit, Eyerich Stefanie, Eyerich Kilian, Jansson Annette F, Ring Johannes, Casanova Jean-Laurent, Renner Ellen D, Traidl-Hoffmann Claudia

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Candidiasis, Chronic Mucocutaneous
Share to Interleukin-17
Share to Interleukin-22

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukins

Share to Mutation

Share to STAT1 Transcription Factor

Share to STAT3 Transcription Factor

Share to Th17 Cells

Source

Identifiers

PMID: 29054602
DOI: 10.1016/j.jid.2017.09.035

Genes

STAT1
STAT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC.PMID 29054602Read ↗

STAT1 and STAT3 mutations: important lessons for clinical immunologistsSemantic proximity Read ↗

Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).Semantic proximity Read ↗

Gain-of-function human <i>STAT1</i> mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasisSemantic proximity Read ↗

A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.Semantic proximity Read ↗

The ups and downs of STAT3 function: too much, too little and human immune dysregulation.Semantic proximity Read ↗

STAT3: an important regulator of multiple cytokine functions.Semantic proximity Read ↗

Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility.Semantic proximity Read ↗

The IL-23/IL-17 pathway in human chronic inflammatory diseases—new insight from genetics and targeted therapiesSemantic proximity Read ↗

STAT1 Hyperphosphorylation and Defective IL12R/IL23R Signaling Underlie Defective Immunity in Autosomal Dominant Chronic Mucocutaneous CandidiasisSemantic proximity Read ↗

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL‐17 immunitySemantic proximity Read ↗

STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases.Semantic proximity Read ↗

Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.